| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.846 | 0.001 | 0.846 | Inosine monophosphate dehydrogenase inhibitor | 0.663 0.001 DBMET00767 0.378 0.002 DBMET00917 0.565 0.001 DBMET00662 | ||
| 0.836 | 0.001 | 0.836 | Inosine monophosphate dehydrogenase 2 inhibitor | 0.628 0.001 DBMET00767 0.197 0.002 DBMET00917 0.244 0.002 DBMET00662 | ||
| 0.82 | 0.011 | 0.95 | Transcription factor NF kappa B inhibitor | 0.798 0.013 DBMET00767 0.943 0.003 DBMET00917 0.95 0.003 DBMET00662 | DBMET00662 | |
| 0.786 | 0.004 | 0.844 | Histamine release inhibitor | 0.827 0.003 DBMET00767 0.844 0.003 DBMET00917 0.798 0.003 DBMET00662 | DBMET00917 | |
| 0.782 | 0.004 | 0.798 | Lipoxygenase inhibitor | 0.798 0.004 DBMET00767 0.188 0.153 DBMET00917 0.263 0.092 DBMET00662 | DBMET00767 | |
| 0.766 | 0.001 | 0.771 | Inosine monophosphate dehydrogenase 1 inhibitor | 0.771 0.001 DBMET00767 0.494 0.001 DBMET00917 0.568 0.001 DBMET00662 | DBMET00767 | |
| 0.77 | 0.019 | 0.865 | Antiinflammatory | 0.825 0.012 DBMET00767 0.865 0.008 DBMET00917 0.859 0.008 DBMET00662 | DBMET00917 | |
| 0.762 | 0.021 | 0.844 | Apoptosis agonist | 0.781 0.019 DBMET00767 0.793 0.017 DBMET00917 0.844 0.011 DBMET00662 | DBMET00662 | |
| 0.718 | 0.005 | 0.728 | Immunosuppressant | 0.728 0.005 DBMET00767 0.714 0.005 DBMET00917 0.726 0.005 DBMET00662 | DBMET00767 | |
| 0.669 | 0.007 | 0.787 | Antioxidant | 0.724 0.005 DBMET00767 0.762 0.005 DBMET00917 0.787 0.004 DBMET00662 | DBMET00662 | |
| 0.589 | 0.009 | 0.697 | Free radical scavenger | 0.642 0.007 DBMET00767 0.676 0.005 DBMET00917 0.697 0.005 DBMET00662 | DBMET00662 | |
| 0.563 | 0.004 | 0.633 | Lipid peroxidase inhibitor | 0.633 0.004 DBMET00767 0.552 0.004 DBMET00917 0.579 0.004 DBMET00662 | DBMET00767 | |
| 0.567 | 0.025 | 0.77 | Antibacterial | 0.597 0.019 DBMET00767 0.748 0.006 DBMET00917 0.77 0.005 DBMET00662 | DBMET00662 | |
| 0.55 | 0.022 | 0.827 | Antithrombotic | 0.571 0.019 DBMET00767 0.827 0.004 DBMET00917 0.788 0.005 DBMET00662 | DBMET00917 | |
| 0.523 | 0.004 | 0.63 | Neurotrophic factor enhancer | 0.63 0.003 DBMET00767 0.54 0.003 DBMET00917 0.442 0.005 DBMET00662 | DBMET00767 | |
| 0.523 | 0.005 | 0.78 | Amylase inhibitor | 0.57 0.004 DBMET00767 0.78 0.002 DBMET00917 0.738 0.003 DBMET00662 | DBMET00917 | |
| 0.525 | 0.007 | 0.839 | Monophenol monooxygenase inhibitor | 0.541 0.006 DBMET00767 0.719 0.004 DBMET00917 0.839 0.003 DBMET00662 | DBMET00662 | |
| 0.486 | 0.022 | 0.513 | Caspase 3 stimulant | 0.513 0.018 DBMET00767 0.453 0.029 DBMET00917 0.482 0.023 DBMET00662 | DBMET00767 | |
| 0.453 | 0.004 | 0.453 | Insulin sensitizer | 0.444 0.005 DBMET00767 0.357 0.009 DBMET00917 0.322 0.012 DBMET00662 | ||
| 0.456 | 0.02 | 0.649 | Hypoglycemic | 0.501 0.015 DBMET00767 0.649 0.006 DBMET00917 0.598 0.008 DBMET00662 | DBMET00917 | |
| 0.457 | 0.026 | 0.557 | Apoptosis antagonist | 0.476 0.024 DBMET00767 0.557 0.014 DBMET00917 0.532 0.016 DBMET00662 | DBMET00917 | |
| 0.434 | 0.004 | 0.473 | Phospholipase A2 inhibitor | 0.473 0.004 DBMET00767 0.378 0.005 DBMET00917 0.36 0.007 DBMET00662 | DBMET00767 | |
| 0.44 | 0.021 | 0.591 | Nitric oxide antagonist | 0.476 0.018 DBMET00767 0.578 0.011 DBMET00917 0.591 0.01 DBMET00662 | DBMET00662 | |
| 0.447 | 0.037 | 0.68 | Immunostimulant | 0.478 0.032 DBMET00767 0.646 0.012 DBMET00917 0.68 0.009 DBMET00662 | DBMET00662 | |
| 0.453 | 0.066 | 0.74 | Cyclophilin D inhibitor | 0.525 0.043 DBMET00767 0.74 0.01 DBMET00917 0.664 0.018 DBMET00662 | DBMET00917 | |
| 0.389 | 0.005 | 0.637 | Mediator release inhibitor | 0.457 0.004 DBMET00767 0.637 0.003 DBMET00917 0.464 0.004 DBMET00662 | DBMET00917 | |
| 0.407 | 0.024 | 0.492 | Hypolipemic | 0.458 0.016 DBMET00767 0.492 0.013 DBMET00917 0.413 0.023 DBMET00662 | DBMET00917 | |
| 0.388 | 0.013 | 0.519 | Melanin inhibitor | 0.414 0.011 DBMET00767 0.519 0.006 DBMET00917 0.512 0.006 DBMET00662 | DBMET00917 | |
| 0.406 | 0.038 | 0.428 | 12-Lipoxygenase inhibitor | 0.428 0.033 DBMET00767 | DBMET00767 | |
| 0.368 | 0.006 | 0.488 | 5-Lipoxygenase inhibitor | 0.488 0.004 DBMET00767 0.088 0.073 DBMET00917 0.141 0.041 DBMET00662 | DBMET00767 | |
| 0.339 | 0.013 | 0.382 | Protein-tyrosine phosphatase inhibitor | 0.382 0.01 DBMET00767 0.268 0.026 DBMET00917 0.278 0.024 DBMET00662 | DBMET00767 | |
| 0.328 | 0.003 | 0.376 | Papain-like protease (SARS coronavirus) inhibitor | 0.376 0.003 DBMET00767 0.234 0.006 DBMET00917 0.24 0.005 DBMET00662 | DBMET00767 | |
| 0.371 | 0.047 | 0.474 | Spasmolytic | 0.362 0.049 DBMET00767 0.442 0.032 DBMET00917 0.474 0.027 DBMET00662 | DBMET00662 | |
| 0.338 | 0.021 | 0.506 | Hepatoprotectant | 0.355 0.018 DBMET00767 0.506 0.007 DBMET00917 0.506 0.007 DBMET00662 | DBMET00662 | |
| 0.344 | 0.035 | 0.465 | Vasodilator | 0.355 0.032 DBMET00767 0.465 0.015 DBMET00917 0.45 0.016 DBMET00662 | DBMET00917 | |
| 0.331 | 0.022 | 0.53 | Non-steroidal antiinflammatory agent | 0.411 0.012 DBMET00767 0.482 0.007 DBMET00917 0.53 0.005 DBMET00662 | DBMET00662 | |
| 0.348 | 0.041 | 0.354 | Sodium/bile acid cotransporter inhibitor | 0.354 0.037 DBMET00767 0.24 0.139 DBMET00917 0.238 0.141 DBMET00662 | DBMET00767 | |
| 0.316 | 0.009 | 0.363 | Protein-tyrosine phosphatase 1B inhibitor | 0.363 0.007 DBMET00767 0.253 0.016 DBMET00917 0.264 0.014 DBMET00662 | DBMET00767 | |
| 0.304 | 0.007 | 0.304 | Antibacterial (Helicobacter pylori) | 0.257 0.011 DBMET00767 0.164 0.036 DBMET00917 0.296 0.007 DBMET00662 | ||
| 0.38 | 0.083 | 0.396 | 15-Lipoxygenase inhibitor | 0.396 0.076 DBMET00767 | DBMET00767 | |
| 0.316 | 0.023 | 0.316 | Gastrin inhibitor | 0.313 0.025 DBMET00767 0.243 0.088 DBMET00917 0.253 0.076 DBMET00662 | ||
| 0.292 | 0.012 | 0.385 | Topoisomerase I inhibitor | 0.302 0.011 DBMET00767 0.342 0.008 DBMET00917 0.385 0.006 DBMET00662 | DBMET00662 | |
| 0.31 | 0.04 | 0.425 | DNA synthesis inhibitor | 0.333 0.034 DBMET00767 0.425 0.019 DBMET00917 0.418 0.019 DBMET00662 | DBMET00917 | |
| 0.27 | 0.014 | 0.299 | DNA polymerase I inhibitor | 0.299 0.011 DBMET00767 0.243 0.018 DBMET00917 0.263 0.015 DBMET00662 | DBMET00767 | |
| 0.29 | 0.037 | 0.419 | Platelet adhesion inhibitor | 0.317 0.029 DBMET00767 0.419 0.01 DBMET00917 0.415 0.01 DBMET00662 | DBMET00917 | |
| 0.268 | 0.015 | 0.309 | Cholesterol synthesis inhibitor | 0.309 0.01 DBMET00767 0.18 0.032 DBMET00917 0.181 0.032 DBMET00662 | DBMET00767 | |
| 0.261 | 0.011 | 0.533 | Expectorant | 0.23 0.015 DBMET00767 0.533 0.003 DBMET00917 0.466 0.004 DBMET00662 | DBMET00917 | |
| 0.373 | 0.126 | 0.781 | Alpha-glucosidase inhibitor | 0.383 0.122 DBMET00767 0.584 0.057 DBMET00917 0.781 0.02 DBMET00662 | DBMET00662 | |
| 0.297 | 0.054 | 0.383 | Platelet antagonist | 0.364 0.035 DBMET00767 0.383 0.031 DBMET00917 0.318 0.047 DBMET00662 | DBMET00917 | |
| 0.303 | 0.064 | 0.309 | Hypoxia-inducible factor 1 alpha inhibitor | 0.309 0.061 DBMET00767 0.259 0.093 DBMET00917 0.305 0.063 DBMET00662 | DBMET00767 | |
| 0.297 | 0.058 | 0.469 | DNA damaging | 0.252 0.079 DBMET00767 0.31 0.053 DBMET00917 0.469 0.017 DBMET00662 | DBMET00662 | |
| 0.235 | 0.004 | 0.248 | Peroxisome proliferator-activated receptor gamma antagonist | 0.248 0.004 DBMET00767 0.082 0.031 DBMET00917 0.077 0.038 DBMET00662 | DBMET00767 | |
| 0.255 | 0.03 | 0.438 | Diuretic | 0.435 0.011 DBMET00767 0.438 0.011 DBMET00917 0.212 0.04 DBMET00662 | DBMET00917 | |
| 0.225 | 0.004 | 0.235 | Glycine receptor agonist | 0.235 0.003 DBMET00767 0.145 0.008 DBMET00917 0.149 0.007 DBMET00662 | DBMET00767 | |
| 0.237 | 0.016 | 0.342 | Antineoplastic antibiotic | 0.257 0.013 DBMET00767 0.319 0.009 DBMET00917 0.342 0.007 DBMET00662 | DBMET00662 | |
| 0.227 | 0.007 | 0.231 | Antineoplastic alkaloid | 0.231 0.007 DBMET00767 0.168 0.023 DBMET00917 0.166 0.023 DBMET00662 | DBMET00767 | |
| 0.228 | 0.013 | 0.248 | Arachidonic acid antagonist | 0.248 0.006 DBMET00767 0.152 0.086 DBMET00917 0.179 0.055 DBMET00662 | DBMET00767 | |
| 0.237 | 0.027 | 0.312 | Bone formation stimulant | 0.312 0.016 DBMET00767 0.177 0.043 DBMET00917 0.188 0.039 DBMET00662 | DBMET00767 | |
| 0.23 | 0.025 | 0.333 | Cyclooxygenase 1 inhibitor | 0.333 0.011 DBMET00767 0.154 0.054 DBMET00917 0.196 0.036 DBMET00662 | DBMET00767 | |
| 0.224 | 0.022 | 0.386 | Cell wall synthesis inhibitor | 0.253 0.015 DBMET00767 0.378 0.007 DBMET00917 0.386 0.006 DBMET00662 | DBMET00662 | |
| 0.209 | 0.011 | 0.209 | Mucolytic | 0.194 0.015 DBMET00767 0.18 0.019 DBMET00917 0.185 0.017 DBMET00662 | ||
| 0.226 | 0.028 | 0.313 | Topoisomerase II inhibitor | 0.218 0.029 DBMET00767 0.292 0.019 DBMET00917 0.313 0.016 DBMET00662 | DBMET00662 | |
| 0.2 | 0.008 | 0.279 | Estrogen receptor alpha antagonist | 0.279 0.005 DBMET00767 | DBMET00767 | |
| 0.287 | 0.1 | 0.48 | Cholesterol antagonist | 0.389 0.052 DBMET00767 0.405 0.048 DBMET00917 0.48 0.036 DBMET00662 | DBMET00662 | |
| 0.34 | 0.154 | 0.516 | Caspase 9 stimulant | 0.29 0.205 DBMET00767 0.362 0.136 DBMET00917 0.516 0.054 DBMET00662 | DBMET00662 | |
| 0.22 | 0.035 | 0.349 | Interferon gamma antagonist | 0.228 0.033 DBMET00767 0.333 0.016 DBMET00917 0.349 0.014 DBMET00662 | DBMET00662 | |
| 0.228 | 0.05 | 0.242 | P-glycoprotein inhibitor | 0.191 0.07 DBMET00767 0.204 0.061 DBMET00917 0.242 0.044 DBMET00662 | DBMET00662 | |
| 0.191 | 0.014 | 0.225 | Estrogen antagonist | 0.225 0.01 DBMET00767 0.127 0.043 DBMET00917 0.131 0.037 DBMET00662 | DBMET00767 | |
| 0.191 | 0.014 | 0.191 | Vanilloid 1 agonist | 0.169 0.024 DBMET00767 0.162 0.028 DBMET00917 0.17 0.023 DBMET00662 | ||
| 0.279 | 0.104 | 0.386 | Angiogenesis inhibitor | 0.261 0.115 DBMET00767 0.36 0.067 DBMET00917 0.386 0.058 DBMET00662 | DBMET00662 | |
| 0.194 | 0.021 | 0.257 | Microtubule formation inhibitor | 0.198 0.02 DBMET00767 0.235 0.013 DBMET00917 0.257 0.007 DBMET00662 | DBMET00662 | |
| 0.185 | 0.014 | 0.48 | AMP-activated protein kinase stimulant | 0.201 0.011 DBMET00767 0.395 0.004 DBMET00917 0.48 0.003 DBMET00662 | DBMET00662 | |
| 0.206 | 0.037 | 0.231 | Interleukin 6 antagonist | 0.207 0.037 DBMET00767 0.231 0.028 DBMET00917 0.216 0.033 DBMET00662 | DBMET00917 | |
| 0.244 | 0.075 | 0.266 | Tyrosine 3 hydroxylase inhibitor | 0.266 0.054 DBMET00767 | DBMET00767 | |
| 0.193 | 0.024 | 0.193 | Farnesoid X receptor antagonist | 0.189 0.025 DBMET00767 0.128 0.086 DBMET00917 0.124 0.095 DBMET00662 | ||
| 0.241 | 0.075 | 0.479 | Antiamyloidogenic | 0.182 0.113 DBMET00767 0.286 0.056 DBMET00917 0.479 0.018 DBMET00662 | DBMET00662 | |
| 0.17 | 0.005 | 0.17 | Bile acid receptor antagonist | 0.155 0.007 DBMET00767 0.107 0.036 DBMET00917 0.095 0.061 DBMET00662 | ||
| 0.173 | 0.008 | 0.213 | Lipase inhibitor | 0.213 0.005 DBMET00767 0.126 0.015 DBMET00917 0.159 0.009 DBMET00662 | DBMET00767 | |
| 0.175 | 0.012 | 0.177 | Electron transport complex I inhibitor | 0.177 0.011 DBMET00767 0.119 0.049 DBMET00917 0.122 0.044 DBMET00662 | DBMET00767 | |
| 0.178 | 0.016 | 0.224 | TRPA1 agonist | 0.224 0.007 DBMET00767 0.13 0.048 DBMET00917 | DBMET00767 | |
| 0.171 | 0.012 | 0.207 | Estrogen receptor beta antagonist | 0.207 0.009 DBMET00767 0.098 0.069 DBMET00917 0.108 0.049 DBMET00662 | DBMET00767 | |
| 0.197 | 0.04 | 0.342 | ATPase inhibitor | 0.166 0.077 DBMET00767 0.342 0.004 DBMET00917 0.294 0.007 DBMET00662 | DBMET00917 | |
| 0.16 | 0.005 | 0.179 | Ca(v)3.1 blocker | 0.179 0.005 DBMET00767 0.077 0.071 DBMET00917 0.094 0.031 DBMET00662 | DBMET00767 | |
| 0.174 | 0.019 | 0.243 | Topoisomerase II alpha inhibitor | 0.161 0.021 DBMET00767 0.208 0.014 DBMET00917 0.243 0.01 DBMET00662 | DBMET00662 | |
| 0.177 | 0.025 | 0.287 | Beta amyloid protein antagonist | 0.116 0.071 DBMET00767 0.183 0.023 DBMET00917 0.287 0.006 DBMET00662 | DBMET00662 | |
| 0.158 | 0.011 | 0.181 | CDC25A inhibitor | 0.181 0.009 DBMET00767 0.089 0.034 DBMET00917 0.087 0.036 DBMET00662 | DBMET00767 | |
| 0.156 | 0.009 | 0.206 | Ornithine decarboxylase inhibitor | 0.206 0.005 DBMET00767 0.103 0.041 DBMET00917 0.085 0.061 DBMET00662 | DBMET00767 | |
| 0.233 | 0.087 | 0.233 | Superoxide dismutase inhibitor | 0.213 0.104 DBMET00767 | ||
| 0.152 | 0.007 | 0.157 | ATPase (Vacuolar H+) inhibitor | 0.152 0.007 DBMET00767 0.157 0.006 DBMET00917 0.15 0.008 DBMET00662 | DBMET00917 | |
| 0.207 | 0.066 | 0.317 | DNA methyltransferase I inhibitor | 0.176 0.083 DBMET00767 0.317 0.021 DBMET00917 0.241 0.051 DBMET00662 | DBMET00917 | |
| 0.184 | 0.048 | 0.312 | NOS3 expression enhancer | 0.202 0.04 DBMET00767 0.297 0.018 DBMET00917 0.312 0.016 DBMET00662 | DBMET00662 | |
| 0.168 | 0.035 | 0.4 | Cyclooxygenase 3 inhibitor | 0.166 0.036 DBMET00767 0.4 0.004 DBMET00917 0.317 0.005 DBMET00662 | DBMET00917 | |
| 0.143 | 0.014 | 0.143 | Peroxisome proliferator-activated receptor gamma agonist | 0.134 0.017 DBMET00767 0.093 0.032 DBMET00917 0.069 0.05 DBMET00662 | ||
| 0.13 | 0.002 | 0.13 | Pregnane X receptor antagonist | 0.123 0.003 DBMET00767 0.057 0.039 DBMET00917 0.071 0.013 DBMET00662 | ||
| 0.178 | 0.052 | 0.237 | Cyclooxygenase inhibitor | 0.237 0.029 DBMET00767 0.126 0.092 DBMET00917 0.149 0.07 DBMET00662 | DBMET00767 | |
| 0.211 | 0.085 | 0.211 | RNA-directed DNA polymerase inhibitor | 0.196 0.105 DBMET00767 0.175 0.142 DBMET00662 | ||
| 0.212 | 0.088 | 0.558 | Angiogenesis stimulant | 0.216 0.087 DBMET00767 0.558 0.009 DBMET00917 0.522 0.011 DBMET00662 | DBMET00917 | |
| 0.145 | 0.025 | 0.145 | Breast cancer-resistant protein inhibitor | 0.13 0.033 DBMET00767 | ||
| 0.168 | 0.05 | 0.168 | Tubulin antagonist | 0.109 0.091 DBMET00767 | ||
| 0.12 | 0.004 | 0.138 | Glucose-6-phosphate translocase inhibitor | 0.121 0.004 DBMET00767 0.138 0.004 DBMET00917 0.138 0.004 DBMET00662 | DBMET00662 | |
| 0.13 | 0.015 | 0.13 | Vanilloid agonist | 0.099 0.035 DBMET00767 0.098 0.035 DBMET00917 0.109 0.025 DBMET00662 | ||
| 0.128 | 0.014 | 0.165 | Leukotriene synthesis inhibitor | 0.165 0.007 DBMET00767 0.063 0.051 DBMET00662 | DBMET00767 | |
| 0.17 | 0.055 | 0.29 | Protein kinase stimulant | 0.165 0.058 DBMET00767 0.29 0.018 DBMET00917 0.231 0.032 DBMET00662 | DBMET00917 | |
| 0.18 | 0.067 | 0.187 | Dual specificity phosphatase inhibitor | 0.187 0.062 DBMET00767 | DBMET00767 | |
| 0.179 | 0.069 | 0.184 | Succinate dehydrogenase inhibitor | 0.184 0.064 DBMET00767 | DBMET00767 | |
| 0.15 | 0.044 | 0.165 | Ca2+-transporting ATPase inhibitor | 0.159 0.025 DBMET00767 0.142 0.067 DBMET00917 0.165 0.018 DBMET00662 | DBMET00662 | |
| 0.12 | 0.016 | 0.144 | Na+ K+ transporting ATPase inhibitor | 0.126 0.013 DBMET00767 0.144 0.007 DBMET00917 0.136 0.009 DBMET00662 | DBMET00917 | |
| 0.191 | 0.089 | 0.2 | Interleukin antagonist | 0.2 0.084 DBMET00767 0.171 0.103 DBMET00917 | DBMET00767 | |
| 0.118 | 0.024 | 0.13 | Glutathione S-transferase inhibitor | 0.13 0.018 DBMET00767 | DBMET00767 | |
| 0.149 | 0.06 | 0.175 | Neurotrophic factor | 0.175 0.041 DBMET00767 0.133 0.076 DBMET00917 0.141 0.068 DBMET00662 | DBMET00767 | |
| 0.092 | 0.004 | 0.094 | DNA gyrase subunit A inhibitor | 0.094 0.004 DBMET00767 0.067 0.008 DBMET00917 0.067 0.008 DBMET00662 | DBMET00767 | |
| 0.18 | 0.093 | 0.312 | DNA methylase inhibitor | 0.158 0.11 DBMET00767 0.312 0.024 DBMET00917 0.265 0.041 DBMET00662 | DBMET00917 | |
| 0.151 | 0.066 | 0.395 | Hemostatic | 0.167 0.051 DBMET00767 0.395 0.008 DBMET00917 0.39 0.008 DBMET00662 | DBMET00917 | |
| 0.104 | 0.02 | 0.111 | Leukotriene antagonist | 0.111 0.018 DBMET00767 0.065 0.044 DBMET00917 0.065 0.045 DBMET00662 | DBMET00767 | |
| 0.126 | 0.049 | 0.131 | MAO A inhibitor | 0.131 0.048 DBMET00767 | DBMET00767 | |
| 0.17 | 0.094 | 0.179 | Anesthetic general | 0.175 0.09 DBMET00767 0.154 0.109 DBMET00917 0.179 0.088 DBMET00662 | DBMET00662 | |
| 0.125 | 0.051 | 0.171 | Photosensitizer | 0.122 0.054 DBMET00767 0.171 0.021 DBMET00917 0.137 0.04 DBMET00662 | DBMET00917 | |
| 0.223 | 0.152 | 0.395 | Interleukin 2 agonist | 0.251 0.117 DBMET00767 0.372 0.037 DBMET00917 0.395 0.029 DBMET00662 | DBMET00662 | |
| 0.103 | 0.036 | 0.124 | Carbonic anhydrase XIII inhibitor | 0.091 0.043 DBMET00767 0.124 0.028 DBMET00917 0.065 0.063 DBMET00662 | DBMET00917 | |
| 0.098 | 0.032 | 0.098 | Keratolytic | 0.08 0.048 DBMET00767 | ||
| 0.146 | 0.085 | 0.288 | Thrombolytic | 0.178 0.063 DBMET00767 0.288 0.026 DBMET00917 0.246 0.035 DBMET00662 | DBMET00917 | |
| 0.07 | 0.009 | 0.086 | Squalene synthetase inhibitor | 0.083 0.008 DBMET00767 0.082 0.008 DBMET00917 0.086 0.007 DBMET00662 | DBMET00662 | |
| 0.083 | 0.023 | 0.108 | Neuraminidase inhibitor | 0.104 0.014 DBMET00767 0.099 0.016 DBMET00917 0.108 0.013 DBMET00662 | DBMET00662 | |
| 0.076 | 0.017 | 0.088 | Leukotriene B4 antagonist | 0.074 0.018 DBMET00767 0.088 0.013 DBMET00917 0.06 0.028 DBMET00662 | DBMET00917 | |
| 0.129 | 0.071 | 0.17 | Cyclooxygenase 2 inhibitor | 0.17 0.042 DBMET00767 0.106 0.096 DBMET00662 | DBMET00767 | |
| 0.21 | 0.152 | 0.461 | Immunomodulator | 0.211 0.151 DBMET00767 0.409 0.041 DBMET00917 0.461 0.029 DBMET00662 | DBMET00662 | |
| 0.058 | 0.004 | 0.061 | Potassium channel (Inward rectifier) 1 blocker | 0.061 0.003 DBMET00767 0.04 0.006 DBMET00917 0.04 0.006 DBMET00662 | DBMET00767 | |
| 0.113 | 0.061 | 0.141 | Chelator | 0.141 0.039 DBMET00767 | DBMET00767 | |
| 0.179 | 0.127 | 0.42 | Tumour necrosis factor alpha release inhibitor | 0.361 0.035 DBMET00917 0.42 0.024 DBMET00662 | DBMET00662 | |
| 0.078 | 0.027 | 0.12 | Neuraminidase (influenza) inhibitor | 0.098 0.017 DBMET00767 0.103 0.015 DBMET00917 0.12 0.012 DBMET00662 | DBMET00662 | |
| 0.068 | 0.019 | 0.091 | Plasminogen activator inhibitor antagonist | 0.091 0.012 DBMET00767 | DBMET00767 | |
| 0.122 | 0.073 | 0.159 | MAO inhibitor | 0.159 0.056 DBMET00767 | DBMET00767 | |
| 0.096 | 0.049 | 0.118 | Androgen antagonist | 0.118 0.034 DBMET00767 | DBMET00767 | |
| 0.076 | 0.029 | 0.076 | Prostaglandin EP2 antagonist | 0.058 0.043 DBMET00767 0.073 0.031 DBMET00917 | ||
| 0.055 | 0.009 | 0.055 | Retinoid X receptor antagonist | 0.055 0.009 DBMET00767 | ||
| 0.122 | 0.076 | 0.122 | Toll-Like receptor 2 antagonist | 0.111 0.089 DBMET00767 | ||
| 0.053 | 0.008 | 0.072 | Peroxisome proliferator-activated receptor alpha antagonist | 0.072 0.006 DBMET00767 | DBMET00767 | |
| 0.061 | 0.018 | 0.079 | Leukocyte elastase inhibitor | 0.079 0.013 DBMET00767 | DBMET00767 | |
| 0.071 | 0.028 | 0.072 | Transcription factor RelA inhibitor | 0.072 0.026 DBMET00767 | DBMET00767 | |
| 0.066 | 0.024 | 0.066 | Peroxisome proliferator-activated receptor alpha agonist | 0.053 0.03 DBMET00767 | ||
| 0.101 | 0.061 | 0.126 | Anabolic | 0.126 0.034 DBMET00767 | DBMET00767 | |
| 0.146 | 0.111 | 0.157 | Lipocortins synthesis antagonist | 0.157 0.095 DBMET00767 | DBMET00767 | |
| 0.059 | 0.024 | 0.059 | Vanilloid 2 antagonist | 0.055 0.03 DBMET00767 | ||
| 0.086 | 0.053 | 0.097 | 3C-Like protease (SARS coronavirus) inhibitor | 0.097 0.036 DBMET00767 | DBMET00767 | |
| 0.044 | 0.011 | 0.044 | Retinoid X alpha receptor antagonist | 0.044 0.01 DBMET00767 | ||
| 0.067 | 0.035 | 0.071 | Transcription factor AP-1 inhibitor | 0.07 0.031 DBMET00767 0.071 0.029 DBMET00917 0.065 0.036 DBMET00662 | DBMET00917 | |
| 0.047 | 0.016 | 0.073 | Nicotinic acid receptor agonist | 0.073 0.008 DBMET00767 | DBMET00767 | |
| 0.068 | 0.037 | 0.093 | HIV-1 integrase (Strand Transfer) inhibitor | 0.093 0.025 DBMET00767 0.051 0.049 DBMET00662 | DBMET00767 | |
| 0.042 | 0.012 | 0.045 | HMG CoA reductase inhibitor | 0.044 0.011 DBMET00767 0.045 0.01 DBMET00917 0.034 0.025 DBMET00662 | DBMET00917 | |
| 0.069 | 0.04 | 0.096 | HIV-1 integrase (3'-Processing) inhibitor | 0.096 0.028 DBMET00767 0.055 0.053 DBMET00662 | DBMET00767 | |
| 0.107 | 0.08 | 0.116 | Caspase 3 inhibitor | 0.116 0.066 DBMET00767 | DBMET00767 | |
| 0.06 | 0.034 | 0.095 | Maillard reaction inhibitor | 0.095 0.019 DBMET00767 | DBMET00767 | |
| 0.075 | 0.051 | 0.08 | Phosphodiesterase VI inhibitor | 0.07 0.061 DBMET00767 0.08 0.041 DBMET00917 0.077 0.046 DBMET00662 | DBMET00917 | |
| 0.105 | 0.081 | 0.363 | Cell adhesion inhibitor | 0.105 0.081 DBMET00767 0.363 0.006 DBMET00917 0.191 0.027 DBMET00662 | DBMET00917 | |
| 0.056 | 0.032 | 0.077 | Estrogen agonist | 0.077 0.024 DBMET00767 0.055 0.032 DBMET00917 0.065 0.028 DBMET00662 | DBMET00767 | |
| 0.096 | 0.076 | 0.17 | Toll-Like receptor 4 antagonist | 0.155 0.018 DBMET00917 0.17 0.013 DBMET00662 | DBMET00662 | |
| 0.069 | 0.049 | 0.078 | HIV-1 integrase inhibitor | 0.078 0.039 DBMET00767 | DBMET00767 | |
| 0.049 | 0.031 | 0.066 | Glucose-6-phosphate isomerase inhibitor | 0.066 0.014 DBMET00767 0.065 0.015 DBMET00917 0.049 0.031 DBMET00662 | DBMET00767 | |
| 0.03 | 0.013 | 0.03 | Retinoid X gamma receptor antagonist | 0.027 0.019 DBMET00767 | ||
| 0.062 | 0.047 | 0.067 | Glucagon-like peptide 1 agonist | 0.067 0.044 DBMET00767 | DBMET00767 | |
| 0.089 | 0.074 | 0.102 | Interleukin 1 beta converting enzyme inhibitor | 0.102 0.055 DBMET00767 | DBMET00767 | |
| 0.056 | 0.041 | 0.064 | Leukotriene C antagonist | 0.064 0.021 DBMET00767 | DBMET00767 | |
| 0.031 | 0.017 | 0.035 | Leukotriene B4 receptor 1 antagonist | 0.035 0.015 DBMET00767 0.024 0.023 DBMET00917 | DBMET00767 | |
| 0.079 | 0.065 | 0.079 | Thioredoxin reductase inhibitor | 0.077 0.072 DBMET00767 0.077 0.072 DBMET00662 | ||
| 0.094 | 0.08 | 0.15 | DNA intercalator | 0.093 0.081 DBMET00767 0.141 0.047 DBMET00917 0.15 0.042 DBMET00662 | DBMET00662 | |
| 0.154 | 0.141 | 0.154 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.153 0.143 DBMET00767 | ||
| 0.035 | 0.024 | 0.038 | Retinoid X alpha receptor agonist | 0.038 0.021 DBMET00767 | DBMET00767 | |
| 0.05 | 0.041 | 0.057 | Elastase inhibitor | 0.057 0.033 DBMET00767 | DBMET00767 | |
| 0.033 | 0.027 | 0.037 | Retinoid X receptor agonist | 0.037 0.024 DBMET00767 | DBMET00767 | |
| 0.139 | 0.133 | 0.14 | Antimitotic | 0.14 0.133 DBMET00662 | DBMET00662 | |
| 0.063 | 0.058 | 0.098 | Prostaglandin-E synthase inhibitor | 0.098 0.028 DBMET00767 | DBMET00767 | |
| 0.06 | 0.056 | 0.114 | Phosphofructokinase-1 inhibitor | 0.109 0.028 DBMET00767 0.114 0.027 DBMET00917 0.077 0.043 DBMET00662 | DBMET00917 | |
| 0.058 | 0.054 | 0.066 | CDC25B inhibitor | 0.066 0.043 DBMET00767 | DBMET00767 | |
| 0.108 | 0.104 | 0.142 | Interleukin 4 antagonist | 0.123 0.08 DBMET00917 0.142 0.058 DBMET00662 | DBMET00662 | |
| 0.029 | 0.026 | 0.035 | Cholesterol ester transfer protein antagonist | 0.035 0.017 DBMET00767 | DBMET00767 | |
| 0.096 | 0.093 | 0.227 | Alkylator | 0.185 0.031 DBMET00917 0.227 0.02 DBMET00662 | DBMET00662 | |
| 0.024 | 0.021 | 0.043 | Leukotriene D4 antagonist | 0.043 0.012 DBMET00767 | DBMET00767 | |
| 0.078 | 0.075 | 0.13 | Transcription factor NF kappa B stimulant | 0.13 0.021 DBMET00917 0.122 0.024 DBMET00662 | DBMET00917 | |
| 0.078 | 0.077 | 0.105 | MAO B inhibitor | 0.105 0.057 DBMET00767 | DBMET00767 | |
| 0.019 | 0.021 | 0.02 | Leukotriene B4 receptor 2 antagonist | 0.02 0.018 DBMET00767 0.02 0.019 DBMET00917 | DBMET00917 | |
| 0.036 | 0.039 | 0.043 | Leukotriene C4 antagonist | 0.043 0.019 DBMET00767 | DBMET00767 | |
| 0.053 | 0.057 | 0.069 | Lipocortins synthesis agonist | 0.055 0.05 DBMET00767 0.065 0.027 DBMET00917 0.069 0.022 DBMET00662 | DBMET00662 | |
| 0.051 | 0.056 | 0.057 | Acetyl-CoA transferase 2 inhibitor | 0.057 0.039 DBMET00767 | DBMET00767 | |
| 0.042 | 0.048 | 0.06 | Aldose reductase inhibitor | 0.047 0.041 DBMET00767 0.06 0.032 DBMET00917 | DBMET00917 | |
| 0.033 | 0.042 | 0.037 | Retinoic acid alpha receptor agonist | 0.037 0.032 DBMET00767 | DBMET00767 | |
| 0.026 | 0.036 | 0.035 | Fumarate hydratase inhibitor | 0.035 0.023 DBMET00767 | DBMET00767 | |
| 0.04 | 0.054 | 0.095 | Protein 50S ribosomal subunit inhibitor | 0.094 0.015 DBMET00917 0.095 0.014 DBMET00662 | DBMET00662 | |
| 0.027 | 0.042 | 0.031 | Peroxisome proliferator-activated receptor delta antagonist | 0.031 0.029 DBMET00767 | DBMET00767 | |
| 0.049 | 0.064 | 0.083 | Adenine nucleotide translocase inhibitor | 0.07 0.015 DBMET00767 0.059 0.031 DBMET00917 0.083 0.008 DBMET00662 | DBMET00662 | |
| 0.115 | 0.13 | 0.123 | Growth hormone agonist | 0.123 0.116 DBMET00767 | DBMET00767 | |
| 0.045 | 0.062 | 0.061 | Thromboxane synthase inhibitor | 0.061 0.026 DBMET00767 | DBMET00767 | |
| 0.034 | 0.052 | 0.045 | Antimetabolite | 0.045 0.035 DBMET00767 | DBMET00767 | |
| 0.046 | 0.064 | 0.057 | Androgen agonist | 0.057 0.045 DBMET00767 | DBMET00767 | |
| 0.083 | 0.104 | 0.253 | Beta glucuronidase inhibitor | 0.1 0.07 DBMET00767 0.157 0.022 DBMET00917 0.253 0.008 DBMET00662 | DBMET00662 | |
| 0.049 | 0.072 | 0.08 | Nitric oxide donor | 0.071 0.031 DBMET00917 0.08 0.022 DBMET00662 | DBMET00662 | |
| 0.034 | 0.057 | 0.055 | Microtubule stabilization | 0.05 0.028 DBMET00917 0.055 0.022 DBMET00662 | DBMET00662 | |
| 0.023 | 0.046 | 0.029 | ATP citrate lysase inhibitor | 0.029 0.028 DBMET00767 | DBMET00767 | |
| 0.076 | 0.103 | 0.127 | GABA C receptor agonist | 0.127 0.045 DBMET00767 | DBMET00767 | |
| 0.075 | 0.108 | 0.094 | Xanthine oxidase inhibitor | 0.089 0.072 DBMET00917 0.094 0.066 DBMET00662 | DBMET00662 | |
| 0.049 | 0.082 | 0.067 | Protease 3C (Human rhinovirus) inhibitor | 0.067 0.04 DBMET00767 | DBMET00767 | |
| 0.072 | 0.108 | 0.085 | T cell inhibitor | 0.085 0.048 DBMET00917 | DBMET00917 | |
| 0.01 | 0.059 | 0.019 | Corticosteroid-like | 0.019 0.018 DBMET00662 | DBMET00662 | |
| 0.122 | 0.18 | 0.163 | Phospholipase C inhibitor | 0.163 0.082 DBMET00767 | DBMET00767 | |
| 0.178 | 0.236 | 0.263 | Antiobesity | 0.263 0.145 DBMET00767 | DBMET00767 | |
| 0.055 | 0.114 | 0.091 | Glycine receptor antagonist | 0.091 0.042 DBMET00917 0.082 0.054 DBMET00662 | DBMET00917 | |
| 0.023 | 0.084 | 0.054 | Thromboxane A2 antagonist | 0.054 0.033 DBMET00767 | DBMET00767 | |
| 0.044 | 0.107 | 0.065 | Glutamate decarboxylase inhibitor | 0.065 0.061 DBMET00767 | DBMET00767 | |
| 0.026 | 0.089 | 0.057 | Thromboxane antagonist | 0.057 0.035 DBMET00767 | DBMET00767 | |
| 0.104 | 0.167 | 0.141 | Adenylate cyclase stimulant | 0.141 0.079 DBMET00767 | DBMET00767 | |
| 0.072 | 0.142 | 0.11 | Phosphodiesterase 6D inhibitor | 0.11 0.036 DBMET00917 0.093 0.068 DBMET00662 | DBMET00917 | |
| 0.047 | 0.118 | 0.069 | Glutamate dehydrogenase inhibitor | 0.069 0.058 DBMET00767 | DBMET00767 | |
| 0.038 | 0.117 | 0.078 | Porphobilinogen synthase inhibitor | 0.078 0.049 DBMET00767 | DBMET00767 | |
| 0.053 | 0.133 | 0.209 | Cell adhesion molecule inhibitor | 0.209 0.009 DBMET00917 0.087 0.045 DBMET00662 | DBMET00917 | |
| 0.082 | 0.163 | 0.118 | Histone deacetylase SIRT1 inhibitor | 0.118 0.094 DBMET00767 | DBMET00767 | |
| 0.053 | 0.134 | 0.074 | Inducible nitric-oxide synthase inhibitor | 0.074 0.073 DBMET00767 | DBMET00767 | |
| 0.139 | 0.228 | 0.334 | Peptidyltransferase inhibitor | 0.334 0.015 DBMET00917 0.309 0.022 DBMET00662 | DBMET00917 | |
| 0.06 | 0.154 | 0.095 | Thioredoxin inhibitor | 0.095 0.055 DBMET00917 | DBMET00917 | |
| 0.056 | 0.152 | 0.089 | Triose-phosphate isomerase inhibitor | 0.082 0.072 DBMET00767 0.089 0.061 DBMET00917 | DBMET00917 | |
| 0.021 | 0.135 | 0.043 | Neuraminidase (Influenza A) inhibitor | 0.043 0.036 DBMET00662 | DBMET00662 | |
| 0.008 | 0.128 | 0.032 | Sodium/glucose cotransporter 2 inhibitor | 0.032 0.011 DBMET00917 0.031 0.012 DBMET00662 | DBMET00917 | |
| 0.022 | 0.164 | 0.279 | Selectin antagonist | 0.279 0.007 DBMET00917 0.266 0.007 DBMET00662 | DBMET00917 | |
| 0.129 | 0.281 | 0.32 | Vasodilator, coronary | 0.32 0.073 DBMET00917 0.304 0.084 DBMET00662 | DBMET00917 | |
| 0.057 | 0.236 | 0.086 | Interleukin 12 antagonist | 0.086 0.081 DBMET00917 | DBMET00917 | |
| 0.008 | 0.2 | 0.026 | Sodium/glucose cotransporter inhibitor | 0.026 0.017 DBMET00917 0.025 0.019 DBMET00662 | DBMET00917 | |
| 0.015 | 0.212 | 0.03 | Toll-Like receptor 4 agonist | 0.027 0.016 DBMET00917 0.03 0.012 DBMET00662 | DBMET00662 | |
| 0.016 | 0.259 | 0.057 | Antibiotic Aminoglycoside-like | 0.057 0.01 DBMET00917 0.052 0.012 DBMET00662 | DBMET00917 | |
| 0.008 | 0.254 | 0.024 | Protein 30S ribosomal subunit inhibitor | 0.023 0.018 DBMET00917 0.024 0.016 DBMET00662 | DBMET00662 | |
| 0.055 | 0.343 | 0.163 | Interleukin agonist | 0.161 0.157 DBMET00917 0.163 0.155 DBMET00662 | DBMET00662 | |
| 0.019 | 0.321 | 0.063 | Heparanase inhibitor | 0.063 0.018 DBMET00917 | DBMET00917 | |
| 0.031 | 0.425 | 0.126 | Anticoagulant | 0.126 0.105 DBMET00917 | DBMET00917 | |
| 0.043 | 0.448 | 0.15 | Insulin secretagoues | 0.15 0.074 DBMET00917 | DBMET00917 | |
| 0.077 | 0.581 | 0.125 | CC chemokine 6 receptor antagonist | 0.125 0.093 DBMET00662 | DBMET00662 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |